john strickler, md, on combo pembrolizumab, trastuzumab, capecitabine & oxaliplatin in mega
Published 5 years ago • 75 plays • Length 0:27
Download video MP4
Download video MP3
Similar videos
-
0:53
david ilson, md, phd, on pembrolizumab, trastuzumab, capecitabine & oxaliplatin in her2 mega
-
0:40
john strickler, md, regarding pembrolizumab vs. chemotherapy in 2nd line advanced esophageal cancer
-
0:36
john strickler, md, on how next-generation sequencing fits into treatment of mcrc
-
0:58
john strickler, md, shares thoughts on molecular subtyping of pancreatic cancer
-
1:04
panthera: pembrolizumab, trastuzumab, and chemotherapy in her2 advanced gastric cancer
-
21:21
inflammasome activation in acute covid-19 - judy lieberman, md, phd
-
5:38
sara's gift - a legacy of hope for gastric cancer patients
-
2:55
how keytruda cancer treatment works (update)
-
3:00
dutreneo trial
-
1:24
dr. catenacci on study of margetuximab plus pembrolizumab in gastric:gej cancer
-
1:40
keynote-811: trastuzumab chemotherapy with or without pembrolizumab for her2 g/gej cancer
-
0:58
combining immunotherapy and chemotherapy in patients with sclc
-
1:47
quality of life results from pembrolizumab vs chemotherapy in gastric or gastroesophageal juncti...
-
6:42
selpercatinib benefit, with or without pembro, in first-line advanced ret fusion-positive nsclc
-
5:40
new treatment options for multiple myeloma
-
0:13
dr. john crispino supports the lrf
-
1:58
where does oxaliplatin fit in the treatment paradigm for advanced metastatic pancreatic cancer?
-
1:00
dr. john zalcberg on regorafenib in refractory advanced oesophago-gastric cancer patients
-
1:22
dr. james mohler discusses prostate cancer trial endpoints
-
18:18
prof. dr. med. christoph driessen, st. gallen: multiple myeloma @ ash 2022: a personal overview
-
17:10
latest advances in precision medicine for prostate and bladder cancer
-
1:15
john strickler: esmo 2019 highlights
Clip.africa.com - Privacy-policy